IndiaTicker
Ask IndiaTicker
IndiaTicker account

Keep your research close.

Save companies, build watchlists and return to your work from any device.

New to IndiaTicker? We create your account automatically. No password.

By continuing, you agree to the Terms and Privacy Policy.

Use an existing password
Company dossier

Jubilant Pharmova

NSE:JUBLPHARMA · ISIN INE700A01033

Close
₹977.4
29 Jul 2026
Daily change
N/A
Exchange close
Evidence state
Building
0/0 checks
Jubilant Pharmova

Filings

Preserved evidence

Primary-source filing timeline

40 recent events
Jubilant Pharmova Ltd - 530019 - Announcement Under Regulation 30 (LODR) - Communication Sent To Shareholders Relating To Notice Of Transfer To IEPFBSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Submission Of Copies Of Newspaper Publications - Annual General Meeting Of Jubilant Pharmova Limited Scheduled To Be Held On Wednesday, August 26, 2026 Through Video Conferencing/Other Audio Visual Means. BSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Shareholders meeting - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Shareholder Meeting / Postal Ballot-Notice of Postal BallotBSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Archived filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Archived filing
Jubilant Pharmova Ltd - 530019 - Disclosure under Regulation 30A of LODRBSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Rectification Order From The Income Tax DepartmentBSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Approval For Grant Of Stock Options/Rsus/PsusBSE · exchange filing · pdf
Source filing
Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Receipt Of Rectification OrderBSE · exchange filing · pdf
Source filing
Trading Window - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Tentative Approval For Panto-Prazole Sodium DRBSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Rectification Order Received From Tax Department In The Matter Of Jubilant Generics LtdBSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Completion Of USFDA InspectionBSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.BSE · shareholding · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - USFDA Inspection Update - Contract Manufacturing Facility At Montreal, CanadaBSE · exchange filing · pdf
Source filing
General Updates - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Earnings Call TranscriptBSE · conference call · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing
Analysts/Institutional Investor Meet/Con. Call Updates - Jubilant Pharmova LimitedNSE · conference call · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing
Copy of Newspaper Publication - Jubilant Pharmova LimitedNSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing
Jubilant Pharmova Ltd - 530019 - Tax Demand Order Received By Company''s Step Down SubsidiaryBSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing
Jubilant Pharmova Ltd - 530019 - Board Meeting Outcome for Outcome Of Meeting Held On May 22, 2026BSE · exchange filing · pdf
Source filing